For the Inventor, By the Inventor

Enter inventor name

San Antonio, TX, United States of America

Bismarck Campos

USPTO Granted Patents = 7 (Patent Applications = 3)

EPO Patents = 1 (Patent Applications = 2)

Average Co-Inventor Count = 5.7

ph-index = 2

Forward Citations = 5(Granted Patents)

Company Filing History:

Curtana Pharmaceuticals, Inc.

Southwest Research Institute

Years Active: 2014-2024

Loading Chart...

Loading Chart...

7 patents (USPTO):Sort by Forward Citations

Abstract keywords

1. 12145913 - Inhibition of Olig2 activity (2024-11-19),

2. 11691951 - Inhibition of Olig2 activity (2023-07-04),

3. 11685722 - Inhibition of Olig2 activity (2023-06-27),

4. 11242323 - Inhibition of OLIG2 activity (2022-02-08),

5. 9169220 - Oximes for treatment of peripheral and central nervous system exposure to acetyl cholinesterase inhibitors (2015-10-27),

6. 8772345 - Oximes for treatment of peripheral and central nervous system exposure to acetyl cholinesterase inhibitors (2014-07-08),

7. 8653108 - Oximes for treatment of peripheral and central nervous system exposure to acetyl cholinesterase inhibitors (2014-02-18),

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

Loading…